4 completed, 1 unknown. 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow ilaprazole: new trials by email Literature Review of ilaprazole trials Research Report on ilaprazole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients Ilaprazole, omeprazole - Peptic Ulcer Hemorrhage | Phase 2 | Completed | Livzon Pharmaceutical Group Inc. | 180 | 2014-02-01 | 2017-12-06 |
| Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients 10 mg ilaprazole, 15 mg ilaprazole, 40 mg esomeprazole - Gastroesophageal Reflux Disease | Phase 2 | Unknown | Livzon Pharmaceutical Group Inc. | 330 | 2010-05-01 | 2010-04-21 |
| Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients 5 mg ilaprazole, 10 mg ilaprazole, 10 mg Rabeprazole - Duodenal Ulcer | Phase 2 / Phase 3 | Completed | Livzon Pharmaceutical Group Inc. | 408 | 2008-08-01 | 2016-07-28 |
| Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive Esophagitis Ilaprazole, Lansoprazole - Esophagitis | Phase 2 | Completed | Takeda | 831 | 2007-05-01 | 2012-02-02 |
| Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 2) 5 mg ilaprazole, 10 mg ilaprazole, 20 mg ilaprazole - Duodenal Ulcer | Phase 2 | Completed | Livzon Pharmaceutical Group Inc. | 235 | 2004-10-01 | 2009-08-06 |
Duodenal Ulcer (2) · Esophagitis (1) · Gastroesophageal Reflux (1) · Heartburn (1) · Peptic Ulcer Hemorrhage (1)
Livzon Pharmaceutical Group Inc. (4) · Takeda (1)
China (1) · United States (1)
Liya Zhou, MD (1) · S R Lin, M.D (1) · Sanren Lin, MD (1)